Page 14 - Delaware Medical Journal - October 2017

Commission on Cancer (CoC) CP3R Measure for Breast Cancer — BCSRT Evaluation of Delaware Cancer Registry Data
Betsy Cromartie, MA, CTR; Bob Hall-McBride, CTR; Zeinab Baba, DrPH, MS
INTRODUCTION
The Delaware Cancer Registry (DCR) is a state central population-based cancer registry, providing data for cancer surveillance and control initiatives of the Division of Public Health as well as statewide, national, and international partners. DCR data meet the standards for data quality, timeliness, and completeness of the Centers for Disease Control and Prevention National Program of Cancer Registries (CDC-NPCR) and the North American Association of Central Cancer Registries (NAACCR). An assessment of quality
of cancer care using DCR data was undertaken to evaluate
the state’s 2014 breast cancer data using Breast Conserving Surgery with Radiation Therapy (BCSRT), an American College of Surgeons Commission on Cancer (CoC) Cancer measure. The BCSRT measure assesses whether radiation therapy was administered within one year (365 days) of diagnosis for women under age 70 receiving breast conserving surgery for breast cancer. This abstract highlights Delaware’s concurrence with the BCSRT measure.
BACKGROUND ON RQRS AND CP3R – QUALITY CANCER TOOLS OF THE COMMISSION ON CANCER
Currently, seven Delaware hospitals have Commission on Cancer (CoC)-accredited cancer programs. The National Cancer Database of the CoC provides a number of tools for use by CoC-accredited cancer programs to evaluate and compare cancer care at their facility with that provided at the state, regional, and national levels. One of these tools, the Rapid Quality Reporting System (RQRS), is designed to be a “close- to-real-time” reporting and alert tool to promote national evidence-based cancer care at the local community level.1 The RQRS utilizes a web-based, systematic data collection and reporting system to promote evidence-based therapy through
a web-based prospective alert system for anticipated care. Utilizing the RQRS enables CoC-accredited cancer programs to evaluate data on patients concurrently, notifying hospitals of treatment expectations, and showing a hospital its year- to-date concordance rate relative to the state, other similar hospitals, and hospitals at the national level. RQRS currently evaluates four breast measures and two colon measures. While RQRS participation had been voluntary, beginning in January 2017, all CoC-accredited cancer programs are required to participate.2
Another tool to promote evaluation and improvement of quality of cancer care is the CoC’s CP3R. CP3R displays a hospital’s record of care, which is used to promote continuous improvement of patient care and enables hospitals to compare adherence to quality of care standards with those of other facilities.3 The CP3R currently reports 23 quality measures covering ten primary cancer sites. BCSRT, which is one of the CP3R measures for quality of breast cancer care, is the focus of this study using statewide cancer registry data.
EVALUATION OF DELAWARE’S CANCER DATA USING CP3R MEASURES
One objective of the Delaware Cancer Registry Advisory Committee (DCRAC) is to improve the quality of Delaware’s cancer data to enable evaluation of treatment practices with patient outcomes. Toward this objective, the DCRAC has promoted usage of the RQRS in Delaware hospitals over the past several years. In a previous study, the DCRAC assessed
the feasibility of reporting on statewide adherence to CP3R colon cancer quality of care measures for Delaware cancer data as a whole.4 In this study, the CoC’s CP3R 12 Regional Lymph Nodes (12RLN) and Adjuvant Chemotherapy (ACT) measures were evaluated for the Delaware Cancer Registry’s colon cancer case. The DCRAC concluded that it is feasible to examine CP3R measures using data from the Delaware Cancer Registry.
302
Del Med J | October 2017 | Vol. 89 | No. 10